Last reviewed · How we verify
Identification and Characterization of Commercial RUO Antibodies for the Detection of Specific Prostate Cancer Tumoral Markers Expressed in Potential Circulating Tumoral Cells (CTCs)
This is an exploratory research study with the aim of identifying specific cancer biomarkers in various subtypes of prostate cancer. Blood samples will be collected from 60 participants divided into 40 patients and 20 healthy donors.
Details
| Lead sponsor | Tethis S.p.A. |
|---|---|
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 60 |
| Start date | 2021-09-09 |
| Completion | 2026-12 |
Conditions
- Prostatic Neoplasms
Primary outcomes
- Number of commercial Antibodies capable of identify specific Prostate Cancer Biomarkers — day 1 : blood collection day
Qualitative assessment of Staining Positivity for different Prostate Cancer Biomarkers
Countries
Italy